| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 210.583 | 84 |
| GSM780708 | Untreated after 4 days (C2_1) | 203.51 | 84 |
| GSM780709 | Untreated after 4 days (C3_1) | 244.538 | 86 |
| GSM780719 | Untreated after 4 days (C1_2) | 245.673 | 86 |
| GSM780720 | Untreated after 4 days (C2_2) | 164.744 | 81 |
| GSM780721 | Untreated after 4 days (C3_2) | 202.433 | 84 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 181.508 | 83 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 211.311 | 84 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 296.064 | 87 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 223.406 | 85 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 181.31 | 83 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 161.962 | 81 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 291.811 | 87 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 255.885 | 86 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 203.356 | 84 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 219.998 | 85 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 206.779 | 84 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 240.611 | 85 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 163.303 | 81 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 165.407 | 82 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 193.483 | 83 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 175.86 | 82 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 162.536 | 81 |